These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21619856)

  • 1. Viral safety in homoeopathic medicinal products.
    Schultz N; Franck-Karl G; Schilk J; Rose N
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):55-65. PubMed ID: 21619856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral safety evaluation of biopharmaceuticals and homoeopathic preparations of human or animal origin.
    Immelmann A
    Pharmeur Sci Notes; 2006 Aug; 2006(1):41-5. PubMed ID: 17694646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Certification of suitability of monographs of the European pharmacopoeia].
    Artiges A
    Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
    Bruckner L
    Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the risk of heavy metal transfer to homoeopathic mother tinctures.
    Busch J; Werner W; Huwer A
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():55-71. PubMed ID: 23327892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk reduction in biotherapeutic products.
    Ill CR; Dehghani H
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Union directives and their effect on the registration and authorisation of anthroposophic and homeopathic medicines.
    Laso LR; Alfonso-Galán MT
    Med Law; 2009 Mar; 28(2):269-82. PubMed ID: 19705642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral safety: European and French directives].
    Rossi F; Legras JF
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S55-61. PubMed ID: 10896992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide perspective in transfusion safety: Europe.
    Reesink HW; Strengers PE
    Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107
    [No Abstract]   [Full Text] [Related]  

  • 12. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C; Motitschke A
    Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory system in europe with special emphasis on allergen products.
    Lorenz AR; Luttkopf D; Seitz R; Vieths S
    Int Arch Allergy Immunol; 2008; 147(4):263-75. PubMed ID: 18648190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework.
    Buchholzer ML; Werner C; Knoess W
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):193-200. PubMed ID: 24384395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Viral safety of biological medicinal products].
    Stühler A; Blümel J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1198-202. PubMed ID: 25123140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current global status of Chinese materia medica.
    Liu X; Zou J; Sheng Z; Su G; Chen S
    Phytother Res; 2009 Oct; 23(10):1493-5. PubMed ID: 19787664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Special therapeutic guidelines from the viewpoint of BfArM (Federal Institute for Drug and Medical Products)].
    Keller K
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):669-74. PubMed ID: 9527466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The harmonization of the regulation of blood products: a European perspective.
    Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
    Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan.
    Chang LC; Kang JJ; Gau CS
    Regul Toxicol Pharmacol; 2016 Jun; 77():252-6. PubMed ID: 27016398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.